Human Liver Model Market By Type (In vitro models, In vivo models, Computational models), By Application (Drug discovery & development, Disease modelling, Regenerative medicine, Educational & training, Others), By Model (2D liver models, 3D liver models), By Technology (3D bioprinting technology, Liver-on-chip technology, Stem cell-based liver models, Computational modelling & simulation), By End-User (Pharmaceutical & biotechnology companies, Academic & research institutions, Hospitals & clinical research centers, Contract research organizations (CROs), Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Human Liver Model Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. How does the rising prevalence of liver diseases like hepatitis and NAFLD drive the demand for human liver models?

3.2.2. In what ways do liver models contribute to safer and more predictive preclinical drug testing?

3.2.3. How are advancements in 3D bioprinting and organ-on-a-chip technologies influencing this market?

3.3. Key industry pitfalls & challenges

3.3.1. How do the high costs of advanced liver models limit their adoption?

3.3.2. What technical challenges exist in replicating full liver functionality in vitro?

3.3.3. How does the limited availability of human primary liver cells affect model development?

3.4. Market Opportunities

3.4.1. How can emerging markets in Asia-Pacific and Latin America expand liver disease research?

3.4.2. What benefits arise from collaborations between biotech firms and academic institutions?

3.4.3. How can personalized liver models improve patient-specific drug testing?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Human Liver Model Market, Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. In vitro models

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. In vivo models

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Computational models

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Human Liver Model Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Drug discovery & development

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Disease modelling

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Regenerative medicine

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Educational & training

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Human Liver Model Market, Model Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Model, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. 2D liver models

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. 3D liver models

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Human Liver Model Market, Technology Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Technology, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. 3D bioprinting technology

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. liver-on-chip technology

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Stem cell-based liver models

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Computational modelling & simulation

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Human Liver Model Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Pharmaceutical & biotechnology companies

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Academic & research institutions

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Hospitals & clinical research centers

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Contract research organizations (CROs)

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Others

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Human Liver Model Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Type, 2025-2035

9.2.3. North America Market Revenue, By Application, 2025-2035

9.2.4. North America Market Revenue, By Model, 2025-2035

9.2.5. North America Market Revenue, By Technology, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Application, 2025-2035

9.2.7.3. U.S. Market Revenue, By Model, 2025-2035

9.2.7.4. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Application, 2025-2035

9.2.8.3. Canada Market Revenue, By Model, 2025-2035

9.2.8.4. Canada Market Revenue, By Technology, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Type, 2025-2035

9.3.3. Europe Market Revenue, By Application, 2025-2035

9.3.4. Europe Market Revenue, By Model, 2025-2035

9.3.5. Europe Market Revenue, By Technology, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Application, 2025-2035

9.3.7.3. Germany Market Revenue, By Model, 2025-2035

9.3.7.4. Germany Market Revenue, By Technology, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Type, 2025-2035

9.3.8.2. France Market Revenue, By Application, 2025-2035

9.3.8.3. France Market Revenue, By Model, 2025-2035

9.3.8.4. France Market Revenue, By Technology, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Application, 2025-2035

9.3.9.3. U.K. Market Revenue, By Model, 2025-2035

9.3.9.4. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Application, 2025-2035

9.3.10.3. Italy Market Revenue, By Model, 2025-2035

9.3.10.4. Italy Market Revenue, By Technology, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Application, 2025-2035

9.3.11.3. Spain Market Revenue, By Model, 2025-2035

9.3.11.4. Spain Market Revenue, By Technology, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Model, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Model, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Type, 2025-2035

9.4.7.2. China Market Revenue, By Application, 2025-2035

9.4.7.3. China Market Revenue, By Model, 2025-2035

9.4.7.4. China Market Revenue, By Technology, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Application, 2025-2035

9.4.8.3. Japan Market Revenue, By Model, 2025-2035

9.4.8.4. Japan Market Revenue, By Technology, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Type, 2025-2035

9.4.9.2. India Market Revenue, By Application, 2025-2035

9.4.9.3. India Market Revenue, By Model, 2025-2035

9.4.9.4. India Market Revenue, By Technology, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Application, 2025-2035

9.4.10.3. Australia Market Revenue, By Model, 2025-2035

9.4.10.4. Australia Market Revenue, By Technology, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Application, 2025-2035

9.4.11.3. South Korea Market Revenue, By Model, 2025-2035

9.4.11.4. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Application, 2025-2035

9.4.12.3. Singapore Market Revenue, By Model, 2025-2035

9.4.12.4. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Model, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Type, 2025-2035

9.5.3. Latin America Market Revenue, By Application, 2025-2035

9.5.4. Latin America Market Revenue, By Model, 2025-2035

9.5.5. Latin America Market Revenue, By Technology, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Application, 2025-2035

9.5.7.3. Brazil Market Revenue, By Model, 2025-2035

9.5.7.4. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Application, 2025-2035

9.5.8.3. Argentina Market Revenue, By Model, 2025-2035

9.5.8.4. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Application, 2025-2035

9.5.9.3. Mexico Market Revenue, By Model, 2025-2035

9.5.9.4. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Application, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Model, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Type, 2025-2035

9.6.3. MEA Market Revenue, By Application, 2025-2035

9.6.4. MEA Market Revenue, By Model, 2025-2035

9.6.5. MEA Market Revenue, By Technology, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Model, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Application, 2025-2035

9.6.8.3. South Africa Market Revenue, By Model, 2025-2035

9.6.8.4. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Model, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. ATCC

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Merck KGaA

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. AcceGen

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. ZenBio, Inc.

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Organovo Holdings Inc.

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. BioIVT

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. InSphero

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Emulate, Inc.

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Mimetas

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. CN Bio Innovations Ltd

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Corning Incorporated

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Cyprotex

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Cellink

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Hurel Corporation

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Cyfuse Biomedical K.K.

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis